10 February 2010, 30 March 2010, 21 April 2010, Palo Alto, CA
Innovator's Workbench
The Innovator's Workbench features top innovators in the biomedical technology field. In this series you'll hear them discuss their process of identifying major critical needs, creating new technologies and how they implemented innovations in patient care. The Workbench events showcase the people who have built the industry and expose the community to their story and lessons learned.
More information at http://biodesign.stanford.edu/bdn/networking/workbench.jsp |
9-11 December 2009, Budapest, Hungary
2009 Bohemian Medical Device Summit
PricewaterhouseCoopers is one of the founders of this invitation-only conference for CEOs from medical device companies. The event provides a private and exclusive setting for networking and partnering. This year's agenda will include high-level panel discussions with keynotes from industry and academic leaders, as well as social networking events.
For futher questions contact: Marina Bello Valcarce
More information at http://www.bohemiansummit.com/ |
3 December 2009, San Mateo, CA
Northern California Hot Topic Roundtable
PricewaterhouseCoopers is hosting this roundtable on Year-End Accounting and Financial Reporting Update.
More information at www.meetpwc.com/pharmaLS |
19-20 November 2009, Philadelphia, PA
VA * DoD * PHS Federal Pricing and Contracts for Bio/Pharmaceutical Companies
One of the largest customers in the United States for bio/pharmaceutical drugs is the U.S. government. Providing lower cost drugs to the VA, DoD, PHS and Coast Guard, also known as the “Big Four”, is both a lucrative and a costly endeavour. Understanding the Veterans Health Care Act and how it impacts Federal Supply Schedule Contracts, the Federal Ceiling Price and the TRICARE Retail Pharmacy Program is critical to any manufacturer wishing to capitalize on this important and competitive market segment.
The various rules, regulations and contract clauses involved in federal contracts create a unique set of challenges which will be covered in this two day conference.
Erinn Hutchinson, Director from the PricewaterhouseCoopers’ Pharmaceutical and Life Sciences practice is featured speaker at this event.
More information at www.cbinet.com |
19 November 2009, San Fancisco, CA
Biotech/Pharma Finance and Accounting Forum
Chief Financial Strategies for Raising Capital, Structuring Deals, Recognizing Revenue and Maximizing Tax Incentives in the Life Sciences Sector
PricewaterhouseCoopers is sponsoring this focused and comprehensive one-day Forum which delves into the accounting and biotech financial reporting issues that matter most in these tough economic times. Our experts from the Pharmaceuticals and Life Sciences practice John Sichack and Robert Ward will be covering “SEC Hot Topics and Current Issues Facing Biotech and Pharmaceutical Companies”
More information at www.cbinet.com |
17-18 November 2009, Philadelphia, PA
4th Annual Pharma/Biotech Tax and Transfer Pricing Congress
PricewaterhouseCoopers is a strategic corporate sponsor of the 4th Annual Tax and Transfer Pricing Congress addressing the tax and transfer pricing issues distinctive to the pharmaceutical and life sciences industry. The meeting provides the platform to keep current on the latest tax rulings, available tax credits for R&D companies and legislative developments impacting state, federal and global taxation. Michael Swanick and Jim Shanahan from our Tax practice will be speaking.
Further details can be found at The Center for Business Intelligence |
11-13 November 2009, Washington, DC
10th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum
The Congress brings together many of the nation’s top pharmaceutical compliance executives and regulators to discuss current and future compliance laws and regulations, and enforcement initiatives affecting the pharmaceutical industry. Brian Riewerts, Anup Kharode, Dave Wysocky and Karla Anderson from PricewaterhouseCoopers' Pharmaceutical & Life Sciences Advisory Services practice are featured speakers.
For more information, please visit http://www.pharmacongress.com/ |
9-11 November 2009, Washington, DC
The Fourth Medical Device Regulatory, Reimbursement and Compliance Congress
The Fourth Medical Device Regulatory, Reimbursement and Compliance Congress (Device Congress) will take place November 9 - 11, 2009 at the JW Marriott Hotel in Washington, DC. The Device Congress will be offered both onsite and online. PricewaterhouseCoopers is a sponsor for this conference on the regulatory and compliance challenges surrounding medical device companies. Doug Mowen, a managing director in our Advisory practice will be presenting.
For more information, please visit www.DeviceCongress.com |
18-21 May 2009, BIO 2009, Atlanta, USA
Annual BIO International Conference
For more information, visit bio2009.org |
25-27 May 2009, Rome, Italy
2009 International Medical Device Industry Compliance, Regulatory and IP Conference
For more information, visit www.advamed.org
PricewaterhouseCoopers' (PwC) Global Pharmaceutical & Life Sciences industry group are Gold sponsors of the 2009 conference.For further information contact: Sara Solomon |
28-29 May 2009, Rome, Italy
The Third International Pharmaceutical Regulatory and Compliance Congress & Best Practices Forum
Sponsored by The Pharmaceutical Compliance Forum
For more information, visit www.internationalpharmacongress.com
PricewaterhouseCoopers' (PwC) Global Pharmaceutical & Life Sciences industry group are diamond sponsors of the 2009 congress. The congress brings together leading industry executives, government regulators and noted industry consultants to discuss changes in the regulatory landscape. PwC's, Governance, Risk and Controls Leader, Brian Riewerts is featured on the agenda as are a number of other firm partners and directors. For further information contact: Sara Solomon |
17-19 June 2009, Monte Carlo
The Biopharmaceutical Conference in Europe
PricewaterhouseCoopers continues to be a key sponsor and supporter of theBiopharmaceutical Conference in Europe and its programme. This exclusive 'by invitationonly' event, provides an unique setting for like-mind individuals, at the most senior levelto meet and explore new business opportunities in a relaxed, informal settingaway from day to day business distractions.The 2009 Biopharmaceutical Conference in Europe will take time to explore financingoptions available, the thinking behind what the buying companies want from new partnersand what target companies need to do to get the best deal for their businesses. Theprogramme will also explore the impact of astonishing new therapeutic technologies thatare slowly making their way into everyday medicine.For further information contact: Art Karacsony and Marina Bello Valcarce Visit: www.biopharmaconference.com |
6-7 May 2009, Minneapolis, USA
8th Annual IBF Medtech Investing Conference
Annual med-device investors Conference to unite the most active investors with entrepreneurs, managers, and strategic players from the medical device industry to network and exchange information on current/future trends, challenges, and areas of opportunity. For more information, visit http://www.medtechconference.com. |
11-12 May 2009, The Grosvenor Hotel, London, UK
Second annual anti-corruption for pharma and life sciences, Sponsored by C5
PricewaterhouseCoopers' (PwC) Forensic Services practice is the lead sponsor for this conference that brings together leaders in the life sciences industry including regulators, in-house counsel, compliance specialists from private practice and consultancies. This faculty of specialists will share their knowledge, best practices and industry-specific solutions for overcoming anti-corruption challenges in your business.
Register for this conference . PWC contacts receive a 10% discount off the conference fee. Please quote priority service code 849L09.SP99 when booking.
|
5-6 March 2009, Washington DC, USA
Summit Disclosure for Drug, Device and Biotech Companies
The First Annual Summit on Sales & Marketing Disclosure for Drug, Device and Biotech Companies will examine the numerous sales and marketing disclosure requirements and how companies are responding. Expert panels and case studies will explore the latest state initiatives and how state and federal enforcers view disclosure as a compliance tool. For more information, visit http://www.disclosuresummit.com . |
16-18 March 2009, Philadelphia, USA
5th Annual Pharmaceutical/ Biotech Accounting and Reporting Congress
Industry-Specific Best Practices for Sound Accounting, Efficient Internal Controls and Compliant Financial Reporting
This meeting provides updates on changing regulations, technical accounting, auditing and financial reporting best practices. Most importantly, it is uniquely tailored for the specific challenges and requirements of pharmaceutical and biotech companies. Information can be found at http://cbinet.com/show_conference.cfm?confCode=PC09139 . |
|
